U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH NIH News
NIH Office of the Director (OD) https://www.nih.gov/institutes-nih/nih-office-director
For Immediate Release: August 10, 2022
CONTACT: NIH Office of Communications, 301-496-5787, <e-mail:nmb@xxxxxxxxxx>
APPOINTMENT OF DR. MONICA BERTAGNOLLI AS DIRECTOR OF THE NATIONAL CANCER INSTITUTE
I am pleased with today's White House announcement that President Biden intends to appoint Monica M. Bertagnolli, M.D., as the 16th Director and first female Director of the National Cancer Institute (NCI). Dr. Bertagnolli's decades of clinical and leadership experience make her ideally suited to lead NCI going forward, including spearheading President Biden's Cancer Moonshot(SM) Initiative.
Dr. Bertagnolli is currently the Richard E. Wilson professor of surgery in the field of surgical oncology at Harvard Medical School, as well as a surgeon at Brigham and Women's Hospital and a member of the Gastrointestinal Cancer and Sarcoma Disease Center at Dana-Farber Cancer Institute. She received her undergraduate degree from Princeton University, her medical degree from the University of Utah School of Medicine and performed her residency at Brigham and Women's Hospital. Dr. Bertagnolli served as an associate surgeon at the Strang Cancer Prevention Institute in New York and as an attending surgeon at New York Presbyterian Hospital-Weill Cornell Medical Center before joining the Dana-Farber Cancer Institute.
A surgeon oncologist, Dr. Bertagnolli specializes in treating gastrointestinal cancers and advocates for increasing the diversity of patients enrolled in clinical trials. She currently serves as vice president of Coalition of Cancer Cooperative Groups, chair of Alliance for Clinical Trials in Oncology, president of the Alliance for Clinical Trials in Oncology Foundation, and CEO of Alliance Foundation Trials, LLC. She formerly served as president of the American Society of Clinical Oncology and was recently elected as a National Academy of Medicine Fellow.
I would like to acknowledge the outstanding leadership of Douglas R. Lowy, M.D., who has been Acting NCI Director since Norman E. "Ned" Sharpless, M.D., stepped down in April 2022 <https://www.nih.gov/news-events/news-releases/norman-sharpless-steps-down-director-national-cancer-institute>. Dr. Lowy's willingness to serve in this role on three separate occasions is testament to his unwavering commitment to furthering the mission of NCI.
Please join me in congratulating Dr. Bertagnolli on her historic appointment and in thanking Dr. Lowy for his remarkable service as he resumes his position as NCI Deputy Director.
Lawrence A. Tabak, D.D.S., Ph.D.
Performing the Duties of the Director of NIH
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office
###
This Statement is available online at:
<https://www.nih.gov/about-nih/who-we-are/nih-director/statements/appointment-dr-monica-bertagnolli-director-national-cancer-institute>
To subscribe (or unsubscribe) from NIH News Release mailings, go to
<http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.
If you subscribed via the NIH LISTSERV, go to <https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.
